Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
07/2008
07/02/2008EP1937254A2 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology
07/02/2008EP1635791B1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation
07/02/2008EP1593666B1 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
07/02/2008EP1501808B1 Tachykinin receptor antagonists
07/02/2008EP1496838A4 Substituted amides
07/02/2008EP1474425B9 Deazapurines and uses thereof
07/02/2008EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
07/02/2008CN201079620Y Medicament controlled-release catheter
07/02/2008CN101212985A Kinin antagonists for treating bladder dysfunction
07/02/2008CN101212961A HMB compositions and uses thereof
07/02/2008CN101209335A Urinemia-treating medicament and preparation thereof
07/02/2008CN101209320A Chinese medicinal granule with heat-clearing and detoxication, hydrops-eliminating and mass-dissipating efficacy
07/02/2008CN101209319A Compound Chinese medicinal granule with heat-clearing and detoxication, damp-clearing and diuresis-promoting efficacy
07/02/2008CN101209295A Chinese herbal medicine preparations for treating nephritis, chronic nephritis and urinemia
07/02/2008CN101209262A Medicine for treating prostatitis
07/02/2008CN101209257A Medical use of baicalin and scutellarein derivatives
07/02/2008CN101209103A Health preserving soup
07/02/2008CN100398544C Aqueous triptolide alcohol derivative with high immunesuppressive activity and its application
07/02/2008CN100398132C Medicine used for kidney supplementing and its preparation method
07/02/2008CN100398106C Use of nk-1 receptor antagonists against benign prostatic hyperplasia
07/02/2008CN100398102C Medicament for kidney failure containing oxaluric acid derivative
07/01/2008US7393932 Endothelial cell expression patterns
07/01/2008US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis
07/01/2008US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
07/01/2008US7393834 LHRH-antagonists in the treatment of fertility disorders
06/2008
06/26/2008WO2008075173A2 Methods for treating podocyte-related disorders
06/26/2008WO2008074860A1 Pharmaceutical composition comprising nicotinamide or nicotinic acid
06/26/2008WO2008074678A1 Novel use of inhibitors of soluble epoxide hydrolase
06/26/2008WO2008074227A1 Synthetic ion channels
06/26/2008WO2008053270A3 Use of an egfr antagonist for the treatment of glomerolonephritis
06/26/2008WO2008036387A8 Method of treating endothelial dysfunction
06/26/2008US20080153899 Fatty amine drug conjugates
06/26/2008US20080153888 Alpha-2-delta ligand/nsaid therapeutic treatment of lower urinary tract disorders
06/26/2008US20080153873 Dihydrobenzofuranyl derivatives and methods of their use
06/26/2008US20080153871 Antagonists of the trpv1 receptor and uses thereof
06/26/2008US20080153835 Therapeutic agents useful for treating pain
06/26/2008US20080153751 Albumin Fusion Proteins
06/26/2008US20080153742 Fas peptide mimetics and uses thereof
06/26/2008US20080152721 Augmentation and repair of spincter defects with cells including adipocytic cells
06/26/2008US20080152709 Clonidine composition and method of use
06/26/2008US20080152629 Progenitor cell culture for use in partial and/or full restoration of hematopoietic function in patients who have undergone ablative therapy
06/26/2008DE102006062111A1 Zusammensetzung, insbesondere für das Blockieren von Kathetern Composition, in particular for blocking catheters
06/26/2008CA2672560A1 Methods for treating podocyte-related disorders
06/26/2008CA2671837A1 Novel use of inhibitors of soluble epoxide hydrolase
06/25/2008EP1935882A1 Bicyclic compounds
06/25/2008EP1935881A1 Aryl-substituted nitrogen-containing heterocyclic compound
06/25/2008EP1935874A1 S1p3 receptor antagonist
06/25/2008EP1935422A1 Pharmaceutical composition comprising nicotinamide or nicotinic acid
06/25/2008EP1935415A2 Treatment of androgen-deprivation induced osteoporosis
06/25/2008EP1934184A1 3 -azabicyclooctane derivatives as muscarinic receptor antagonists
06/25/2008EP1933855A1 Smooth muscle implant for managing a medical condition
06/25/2008EP1725552B1 New quaternized quinuclidine esters
06/25/2008EP1572181B1 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor and the use of said composition for treating bladder dysfunction
06/25/2008EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain
06/25/2008EP1377164B1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
06/25/2008EP1351683B1 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
06/25/2008EP1286962B1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
06/25/2008CN101204553A Chinese traditional medicine for uroclepsia, impotence and prospermia and preparation method thereof
06/25/2008CN101204532A Medicine for prostate disease and preparation method thereof
06/25/2008CN101204517A Chinese traditional medicine for nephropathy
06/25/2008CN101204516A Peroral Chinese traditional medicine for lung-heat enuresis
06/25/2008CN101204506A Chinese traditional medicine prescription for recurrent nephrotic syndrome
06/25/2008CN101204495A Peroral Chinese traditional medicine composition for chronic nephritis
06/25/2008CN101204493A Peroral Chinese traditional medicine composition for chronic nephritis
06/25/2008CN101204492A Medicated health-caring wine
06/25/2008CN101204491A Medicated health care kidney-nourishing wine
06/25/2008CN101204481A Chinese traditional medicine for chronic nephritis
06/25/2008CN101204464A Tianqi capsule for Kidney-Reinforcing
06/25/2008CN101204387A Novel tamsulosin hydrochloride sustained release capsules
06/25/2008CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/25/2008CN100396282C Slow released doxazosin mesilate capsule and its preparation process
06/24/2008US7392233 Image searching system, image searching method, and a recording medium storing an image searching program
06/24/2008US7390924 Terphenyl derivatives, preparation thereof, compositions containing same
06/24/2008US7390812 N, N'-disubstituted piperazine compounds and their use as analgesics
06/24/2008US7390797 Fused indazole compounds
06/24/2008US7390668 Halogenated xanthan compound
06/24/2008US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation
06/24/2008US7390519 Probiotic Lactobacillus salivarius strains
06/24/2008US7390484 Self-contained adipose derived stem cell processing unit
06/19/2008WO2008073388A2 Alfuzosin formulations, methods of making and methods of use
06/19/2008WO2008073292A2 Method for protecting renal tubular epithelial cells from radiocontrast nephro parhy (rcn)
06/19/2008WO2008073040A1 Use of a phytosterol containing composition for the treatment of luts.
06/19/2008WO2008072779A1 Quinoxaline derivative
06/19/2008WO2008072778A1 Therapeutic agent for urinary tract disease
06/19/2008WO2008072726A1 1-phenyl 1-thio-d-glucitol derivative
06/19/2008WO2008072591A1 Iron metabolism-improving agent
06/19/2008WO2008071245A1 Pharmaceutical preparation for the treatment of inflammatory diseases of the urogenital tract
06/19/2008WO2008070995A1 Methods and treatments for prevention of acute renal failure following cardiac surgery
06/19/2008WO2008051980A3 Methods of reducing phosphate absorption
06/19/2008US20080146663 Derivatives of 11-nonyloxy-undec-8(Z)-eonic acid, e.g., (Z)-1,3-dihydroxypropan-2-yl 11-(nonyloxy)undec-8-enoate; compounds mimic epoxide metabolites; for use in treatment of renal or cardiovascular disease; hypotensive agents
06/19/2008US20080146639 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment
06/19/2008US20080146604 adenosine receptor antagonists such as 2-(4-Methoxyphenyl)-9-benzylamino-10-cyano-s-triazolo[1,5-a]quinolin, used for treating respiratory system disorders, vision disorders, tumors, allergies or inflammatory disease, ischemia, hypoxia, arrhythmia or urogential disorders
06/19/2008US20080146588 Piperidinyl Piperidine Tachykinin Receptor Antagonists
06/19/2008US20080146583 Treatment of Incontinence
06/19/2008US20080146533 Containing tertiary amine linked pyrrolidine, azetidine, morpholine or piperidine group; inhibiting GlyCer synthase, lowering glycosphingolipid levels; collagen vascular diseases, atherosclerosis, diabetic renal hypertrophy
06/19/2008US20080146531 Therapeutically Active Triazoles and Their Use
06/19/2008US20080146503 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins
06/19/2008CA2672591A1 Treating agent of uropathy
06/19/2008CA2672512A1 Use of a phytosterol containing composition for the treatment of luts
06/19/2008CA2672176A1 1-phenyl 1-thio-d-glucitol derivative